⌘K

Home/Filings/4/0001415889-25-019382

4//SEC Filing

Carulli Michael 4

Accession 0001415889-25-019382

CIK 0001699382other

View on SEC.gov Company Profile

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 7:49 PM ET

Size

4.9 KB

Accession

0001415889-25-019382

Insider Transaction Report

Form 4

Period: 2025-07-01

PMV Pharmaceuticals, Inc.PMVP

Carulli Michael

Chief Financial Officer

Transactions

Sale
Common Stock
2025-07-01$1.06/sh−28,249$30,077→ 60,146 total

Footnotes (1)

[F1]The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

Documents

1 file

4
form4-07032025_110716.xmlPrimary

Issuer

PMV Pharmaceuticals, Inc.

CIK 0001699382

Entity typeother

Related Parties

1

filerCIK 0002006668

Filing Metadata

Form type: 4
Filed: Jul 2, 8:00 PM ET
Accepted: Jul 3, 7:49 PM ET
Size: 4.9 KB

View on SEC.gov